Clinical Trial Update: STREAMER : STent Restenosis And MEdicaments Release [Phase 3]

View source ↗

Summary

The STREAMER Phase 3 trial evaluating a drug-eluting stent for restenosis in critical limb ischemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Limb Ischemia

Drugs mentioned

• STREAMER drug-eluting stent

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Critical Ischemia | Phase 3 | Status: COMPLETED